Artificial Intelligence in Drug Discovery – A Vision by Dr. Zahraa Khalifa
Introduction
In the fast-evolving world of pharmaceutical sciences, artificial intelligence (AI) has become a game-changer in accelerating drug discovery and improving therapeutic outcomes. At the forefront of this transformation stands Dr. Zahraa Khalifa, a distinguished academic and researcher from Dubai Pharmacy College for Girls, UAE. With her expertise in drug delivery and innovative research on AI integration, Dr. Khalifa bridges the gap between traditional pharmaceutical sciences and cutting-edge technology, paving the way for smarter, faster, and more efficient drug development.
Attending Dr. Zahraa Khalifa’s session, “Artificial Intelligence Across the Drug Discovery Pipeline: From Molecule to Market,” offers participants a comprehensive understanding of how AI is reshaping the pharmaceutical industry. Delegates will gain insights into the use of AI in molecular design, compound screening, and clinical trials — all aimed at optimizing drug development processes and reducing time-to-market. Her session will also highlight real-world applications of AI-driven tools and predictive analytics in enhancing precision medicine, making it an invaluable experience for researchers, academicians, and industry professionals alike.
Research Interests of the Speaker
Dr. Khalifa’s primary research interests lie in drug delivery systems, nanotechnology, and AI-assisted drug discovery. Her work focuses on the formulation of advanced drug delivery mechanisms that improve bioavailability and patient outcomes. Combining her scientific background with expertise in artificial intelligence, she explores how machine learning models can accelerate molecular prediction, formulation design, and data-driven decision-making within the pharmaceutical field.
Awards, Recognition, and Achievements
Dr. Zahraa Khalifa holds a PhD in Pharmaceutical Sciences (Drug Delivery) from the University of Strathclyde, UK, one of the leading institutions in pharmaceutical research. She also earned a Postgraduate Certificate in Artificial Intelligence in Drug Discovery from the London School of International Business, underscoring her commitment to technological innovation in healthcare. With over a decade of experience in teaching and research, Dr. Khalifa has authored multiple Scopus-indexed publications, contributing significantly to the global body of pharmaceutical knowledge. Her dedication to advancing pharmaceutical education and mentorship continues to inspire students and researchers across the Middle East.
Important Links:
Submit Abstract: https://nursing.utilitarianconferences.com/submit-abstract
Register Here: https://nursing.utilitarianconferences.com/registration
Email: info-ucg@utilitarianconferences.com
Facebook: https://www.facebook.com/g.priyanka.92798/
LinkedIn: https://www.linkedin.com/in/nursingutilitarianconferences/
Instagram: https://www.instagram.com/nursingucg/
Conclusion
Dr. Zahraa Khalifa’s work exemplifies the synergy between science and technology in modern drug discovery. Through her expertise and forward-thinking approach, she is shaping the future of pharmaceutical innovation and inspiring the next generation of scientists to embrace AI as a powerful tool for healthcare transformation. Attending her session promises to be a transformative experience for anyone passionate about the intersection of technology and medicine.
#Tags:
#DrZahraaKhalifa #ArtificialIntelligence #DrugDiscovery #PharmaceuticalSciences #DrugDelivery #AIinHealthcare #PharmaInnovation #UAEPharmacy #WomenInScience #Nanotechnology #MedicalResearch #PharmaceuticalEducation #HealthcareInnovation
Comments
Post a Comment